Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.900
+0.031 (3.51%)
At close: Nov 20, 2024, 4:00 PM
0.920
+0.020 (2.22%)
After-hours: Nov 20, 2024, 7:15 PM EST
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $65.36 million as of November 21, 2024. Its market cap has decreased by -28.43% in one year.
Market Cap
65.36M
Enterprise Value
19.71M
1-Year Change
-28.43%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $65.36M, an increase of 45.10%. That is a compound annual growth rate of 10.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 65.36M | -18.49% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monogram Technologies | 64.67M |
| Celularity | 64.20M |
| AlloVir | 63.92M |
| enVVeno Medical | 63.30M |
| Metagenomi | 63.25M |
| X4 Pharmaceuticals | 62.76M |
| Spero Therapeutics | 62.70M |
| Xtant Medical Holdings | 62.57M |